Common Contracts
3 similar License Agreement contracts by Immunogen Inc
EX-10.1 2 a07-13240_1ex10d1.htm EX-10.1 EXECUTION COPY LICENSE AGREEMENTLicense Agreement • May 5th, 2020 • California
This License Agreement (the “Agreement”) is made effective as of April 27, 2005 (the “Effective Date”) by and between GENENTECH, INC., a Delaware corporation having its principal business office at 1 DNA Way, South San Francisco, California 94080 (“GENENTECH”), and IMMUNOGEN, INC., a Massachusetts corporation with its principal place of business at 128 Sidney Street, Cambridge, Massachusetts 02139 (“IMMUNOGEN”). GENENTECH and IMMUNOGEN are each hereafter referred to individually as a “Party” and together as the “Parties”.
LICENSE AGREEMENTLicense Agreement • May 9th, 2007 • Immunogen Inc • Pharmaceutical preparations • California
This License Agreement (the “Agreement”) is made effective as of April 27, 2005 (the “Effective Date”) by and between GENENTECH, INC., a Delaware corporation having its principal business office at 1 DNA Way, South San Francisco, California 94080 (“GENENTECH”), and IMMUNOGEN, INC., a Massachusetts corporation with its principal place of business at 128 Sidney Street, Cambridge, Massachusetts 02139 (“IMMUNOGEN”). GENENTECH and IMMUNOGEN are each hereafter referred to individually as a “Party” and together as the “Parties”.
LICENSE AGREEMENTLicense Agreement • May 9th, 2007 • Immunogen Inc • Pharmaceutical preparations • California
This License Agreement (the “Agreement”) is made effective as of December 12, 2005 (the “Effective Date”) by and between GENENTECH, INC., a Delaware corporation having its principal business office at 1 DNA Way, South San Francisco, California 94080 (“GENENTECH”), and IMMUNOGEN, INC., a Massachusetts corporation with its principal place of business at 128 Sidney Street, Cambridge, Massachusetts 02139 (“IMMUNOGEN”). GENENTECH and IMMUNOGEN are each hereafter referred to individually as a “Party” and together as the “Parties”.
